- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: INSULIN GLARGINE (U300)
Total 4023 results
-
Eli Lilly and CompanyRecruitingCardiovascular Diseases | Obesity | Overweight | Type 2 Diabetes | Chronic Kidney Disease | Overweight or ObesityUnited States, Italy, Spain, Korea, Republic of, India, Turkey, Austria, Puerto Rico, Mexico, Romania, Brazil, Czechia, Germany, Argentina, Greece, Slovakia
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusIndia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Germany
-
Emory UniversityCompletedHyperglycemiaUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedDiabetes MellitusSingapore
-
SanofiPopulation Health Research InstituteCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States, France, Brazil, Poland, Romania, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, India, Philippines, Russian Federation, Slovakia, Mexico, Argentina, Croatia, Austria, Denmark, Finland, Hungary, Lithuania, Norw... and more
-
Sansum Diabetes Research InstituteNovo Nordisk A/SCompletedDiabetes Mellitus, Type 1United States
-
Amsterdam UMC, location VUmcCompletedObesity | Type 2 DiabetesNetherlands
-
SanofiCompletedDiabetes Mellitus, Type 2Russian Federation, United States, United Kingdom
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany
-
SanofiCompleted
-
Emory UniversityMerck Sharp & Dohme LLCCompletedHyperglycemia | Type 2 Diabetes Mellitus | HospitalizationUnited States
-
University of Alabama at BirminghamRecruitingDiabetes Mellitus, Type 2 | Preterm Birth | Pregnancy, High Risk | Diabetes, GestationalUnited States
-
Emory UniversityNovo Nordisk A/SCompleted
-
Nanjing First Hospital, Nanjing Medical UniversityUnknown
-
University of the Highlands and IslandsCompletedEndothelial DysfunctionUnited Kingdom
-
Eli Lilly and CompanyBoehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Mexico, Korea, Republic of, Germany, Poland, Taiwan, Spain, Greece, France, Czech Republic, Hungary
-
SanofiCompletedDiabetes Mellitus, Type 2Japan, Russian Federation, China, India, Pakistan, Philippines
-
The Coca-Cola CompanyCompletedObesity | OverweightSpain
-
HealthPartners InstituteTerminated
-
Profil Institut für Stoffwechselforschung GmbHSanofiCompleted
-
SanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesItaly, Poland, Denmark, France, Netherlands, Austria, Spain, Finland, Argentina, India, Russian Federation, United Kingdom, Slovakia, Brazil, Norway, Former Serbia and Montenegro, South Africa, Philippines
-
Medtronic DiabetesCompletedType 1 DiabetesUnited States
-
Novo Nordisk A/SCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2France, Germany, Netherlands, Spain, Sweden, Switzerland, United Kingdom, Finland, Italy, Austria
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusSweden, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Estonia, Romania, Finland, Netherlands, Argentina, Belgium, Germany, Portugal, United Kingdom, Greece, France, Puerto Rico
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingType 2 DiabetesUnited States
-
Hospital Central "Dr. Ignacio Morones Prieto"CompletedAngiogenesis | Varicose Ulcer | Insulin | Wound Healing | Chronic Venous DiseaseMexico
-
Eli Lilly and CompanyCompletedDiabetes MellitusSouth Africa
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Germany
-
Northwestern UniversityTerminatedInsulin Resistance, Diabetes | Hyperglycemia Steroid-inducedUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United Kingdom, United States, Australia, Canada, Poland, Denmark, Spain, Croatia, Sweden, Greece, Belgium, France, New Zealand, South Africa, Israel, Brazil, Ireland, Netherlands, Lithuania, Slovakia
-
Eli Lilly and CompanyCompleted
-
University of GuadalajaraCompletedType 2 Diabetes MellitusMexico
-
Eli Lilly and CompanyCompletedA Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes PatientsDiabetes Mellitus, Type 2Romania, Italy, Belgium, Poland, Greece, Germany, United Kingdom, Turkey, Czech Republic, Slovakia
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Argentina, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, France, Germany, Hungary, India, Israel, Italy, Malaysia, Mexico, Netherlands, Poland, Puerto Rico, Romania, Russian Federation, South Africa, Swed... and more
-
SanofiCompletedType 2 Diabetes MellitusUkraine
-
GeropharmCompletedDiabetes Mellitus, Type 2Russian Federation
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
SanofiCompleted
-
Chungbuk National University HospitalActive, not recruitingType 2 Diabetes Mellitus | Glucose, High BloodKorea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited Arab Emirates, Malaysia, India, South Africa, Algeria, Lebanon
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Austria, Switzerland, United Kingdom, Germany, Ireland